{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["24(2)"],"submitter":["Tebaldi M"],"funding":["Boston Scientific"],"pubmed_abstract":["<h4>Background</h4>Recently, questions around the efficacy and effectiveness of Fractional Flow Reserve (FFR) have arisen in various clinical settings.<h4>Methods</h4>The Clinical Outcome of FFR-guided Revascularization Strategy of Coronary Lesions (HALE-BOPP) study is an investigator-initiated, multicentre, international prospective study enrolling patients who underwent FFR measurement on at least one vessel. In accordance with the decision-making workflow and treatment, the vessels were classified in three subgroups: (i) angio-revascularized, (ii) FFR-revascularized, (iii) FFR-deferred. The primary endpoint was the occurrence of target vessel failure (TVF, cardiac death, target vessel myocardial infarction and ischemia-driven target vessel revascularization). The analysis was carried ou"],"journal":["Reviews in cardiovascular medicine"],"pagination":["62"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11273154"],"repository":["biostudies-literature"],"pubmed_title":["Clinical Outcome of FFR-Guided Revascularization Strategy of Coronary Lesions: The HALE-BOPP Study."],"pmcid":["PMC11273154"],"pubmed_authors":["Tedeschi D","Cortese B","Pompei G","Gibiino F","Durante A","Ielasi A","Arena M","Marrone A","Barbato E","Watkins S","Scala A","Tebaldi M","Gallo F","Pavasini R","Serenelli M","Campo G","Caglioni S","Scollo E","Biscaglia S","Mele D","Verdoliva S","Scoccia A","D'Aniello E","Valentini G","Bilotta F"],"additional_accession":[]},"is_claimable":false,"name":"Clinical Outcome of FFR-Guided Revascularization Strategy of Coronary Lesions: The HALE-BOPP Study.","description":"<h4>Background</h4>Recently, questions around the efficacy and effectiveness of Fractional Flow Reserve (FFR) have arisen in various clinical settings.<h4>Methods</h4>The Clinical Outcome of FFR-guided Revascularization Strategy of Coronary Lesions (HALE-BOPP) study is an investigator-initiated, multicentre, international prospective study enrolling patients who underwent FFR measurement on at least one vessel. In accordance with the decision-making workflow and treatment, the vessels were classified in three subgroups: (i) angio-revascularized, (ii) FFR-revascularized, (iii) FFR-deferred. The primary endpoint was the occurrence of target vessel failure (TVF, cardiac death, target vessel myocardial infarction and ischemia-driven target vessel revascularization). The analysis was carried ou","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Feb","modification":"2026-04-08T15:25:15.061Z","creation":"2026-04-08T04:31:19.376Z"},"accession":"S-EPMC11273154","cross_references":{"pubmed":["39077421"],"doi":["10.31083/j.rcm2402062"]}}